Table 2.
Demographic characteristics, baseline values and humoral immune response induced at T1 and T2 time-points by different vaccines in healthy adults and frail elderly individuals with previously reported COVID-19 diagnosis.
| Ex-COVID1-dose <65 | Ex-COVID2-dose <65 | Ex-COVID1-dose ≥65 | Ex-COVID2-dose ≥65 | |
|---|---|---|---|---|
| N=118 | 51 | 14 | 34 | 19 |
| Median age (IQR) | 51 (45 - 57) | 68 (66 - 71.75) | 47 (34 - 55) | 76 (72.5 - 78.5) |
| % Female | 56.86 | 50 | 47.06 | 42.11 |
| % T0 > 33.8 | 94.12 | 92.86 | 73.53 | 94.74 |
| % T1 > 33.8 | 100 | 100 | 100 | 100 |
| % T2 > 33.8 | 100 | 92.86 | 100 | 100 |
| GMT T0 (Range) | 126.6 (4.81 - 2080) | 246.61 (4.81 - 681) | 53.43 (4.81 - 618) | 102.22 (4.81 - 711) |
| GMT T1 (Range) | 5847.75 (1440 - 37600) | 4856.54 (34.2 - 21300) | 7121.97 (1450 - 33800) | 7627.06 (186 - 40200) |
| GMT T2 (range) | 1556.36 (262 - 22800) | 1667.61 (19.2 - 16100) | 2622.08 (688 - 29400) | 3804.02 (36.8 - 39800) |